These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 4393719)

  • 1. Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.
    Frick MH; Katila M
    Fortn Rev Chic Dent Soc; 1970 Sep; 60(5):96-101. PubMed ID: 4393719
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of angina pectoris with cardioselective beta blocking agents. Double blind study with Eraldin (practolol)].
    Erikssen J; Rod T
    Tidsskr Nor Laegeforen; 1971 Apr; 91(10):721-5. PubMed ID: 4397025
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of the effects of propranolol and practolol on the exercise tolerance in angina pectoris.
    Coltart DJ; Hamer J
    Br J Pharmacol; 1970 Sep; 40(1):147P-148P. PubMed ID: 4395080
    [No Abstract]   [Full Text] [Related]  

  • 4. The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris.
    Aellig WH; Prichard BN; Richardson GA
    Br J Pharmacol; 1969 Oct; 37(2):527P-528P. PubMed ID: 4390674
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenergic beta-blockade in angina pectoris. A study of the effects of Practolol (Eraldin, I.C.I. 50172) with special attention to the matter of dosage].
    Christensen E; Busch M
    Ugeskr Laeger; 1971 Feb; 133(7):296-9. PubMed ID: 4396025
    [No Abstract]   [Full Text] [Related]  

  • 6. Practolol in treatment of angina pectoris. A double-blind trial.
    George CF; Nagle RE; Pentecost BL
    Br Med J; 1970 May; 2(5706):402-4. PubMed ID: 4392984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practolol in patients with angina pectoris.
    Alderman EL; Davis RO; Friedman JP; Graham AF; Matlof HJ; Harrison DC
    Clin Pharmacol Ther; 1973; 14(2):175-81. PubMed ID: 4144425
    [No Abstract]   [Full Text] [Related]  

  • 8. Practolol in the treatment of ischaemic heart pain. Results of a controlled trial.
    Nestel PJ
    Med J Aust; 1972 May; 1(20):1033-5. PubMed ID: 4626799
    [No Abstract]   [Full Text] [Related]  

  • 9. Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.
    Arstila M; Iisalo E; Kallio V
    Ann Clin Res; 1969 May; 1(1):13-21. PubMed ID: 4390794
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial of two beta blockade drugs, Ciba 39089 and ICI 50172, in angina pectoris.
    Nellen M
    S Afr Med J; 1969 Dec; ():Suppl:15-7. PubMed ID: 4392020
    [No Abstract]   [Full Text] [Related]  

  • 11. -Receptor antagonists in angina pectoris.
    Prichard BN
    Ann Clin Res; 1971 Dec; 3(6):344-52. PubMed ID: 4400460
    [No Abstract]   [Full Text] [Related]  

  • 12. Practolol in angina.
    Phear DN
    Br Med J; 1971 Mar; 1(5748):557. PubMed ID: 4396083
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of practolol on exercise tolerance in patients with angina pectoris.
    Sowton E; Smithen C; Leaver D; Barr I
    Am J Med; 1971 Jul; 51(1):63-70. PubMed ID: 4398290
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
    Sandler G; Clayton GA
    Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of practolol on angina pectoris induced by atrial pacing.
    Gavrilescu S; Streian C; Pop T
    Cor Vasa; 1972; 14(4):259-64. PubMed ID: 4146675
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanism of action of beta-adrenergic receptor blocking agents in angina pectoris: comparison of action of propranolol with dexpropranolol and practolol.
    Wilson AG; Brooke OG; Lloyd HJ; Robinson BF
    Br Med J; 1969 Nov; 4(5680):399-401. PubMed ID: 4390958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penbutolol--a sinistrorotatory adrenergic beta-receptor blocking agent. Ergometer investigations in patients with angina pectoris].
    Prahl P; Prahl M
    Ugeskr Laeger; 1973 May; 135(20):965-8. PubMed ID: 4148295
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stress tests limited by the symptoms in the evaluation of drug treatment of angina pectoris].
    Broustet JP; Pic A; Laurentjoye P; Douard H; Mora B
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():17-24. PubMed ID: 6134507
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exercise tolerance in patients with angina pectoris with the beta blockader alprenol].
    Liljedal J
    Tidsskr Nor Laegeforen; 1971 Jul; 91(19):1451-8. PubMed ID: 4398226
    [No Abstract]   [Full Text] [Related]  

  • 20. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.